A European multicentre PET study of fibrillar amyloid in Alzheimer's disease

Agneta Nordberg, Stephen F Carter, Juha Rinne, Alexander Drzezga, David Brooks, Rik Vandenberghe, Daniela Perani, Anton Forsberg, Bengt Långström, Noora Scheinin, Mira Karrasch, Kjell Någren, Timo Grimmer, Isabelle Miederer, Paul Edison, Aren Okello, Koen Van Laere, Natalie Nelissen, Mathieu Vandenbulcke, Valentina GaribottoOve Almkvist, Elke Kalbe, Rainer Hinz, Karl Herholz

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

Abstrakt

Amyloid PET tracers have been developed for in vivo detection of brain fibrillar amyloid deposition in Alzheimer's disease (AD). To serve as an early biomarker in AD the amyloid PET tracers need to be analysed in multicentre clinical studies.
OriginalsprogEngelsk
TidsskriftEuropean Journal of Nuclear Medicine and Molecular Imaging
Vol/bind40
Udgave nummer1
Sider (fra-til)104-14
Antal sider11
ISSN1619-7070
DOI
StatusUdgivet - 2013
Udgivet eksterntJa

Fingeraftryk Dyk ned i forskningsemnerne om 'A European multicentre PET study of fibrillar amyloid in Alzheimer's disease'. Sammen danner de et unikt fingeraftryk.

Citationsformater